LONDON, UK / ACCESSWIRE / October 27, 2023 / LINLINE MEDICAL SYSTEMS, based in Riga, Latvia, has demonstrated the remarkable effectiveness of its distinctive RecoSMA laser technology in treating chronic wounds. The recent study, "Spatially modulated erbium YAG laser as a treatment for diabetic ulcer", published in the Journal of Wound Care (UK), was conducted using a MULTILINE laser system produced by the company.

The mean wound surface area at baseline was 25.7 cm2. The average number of laser treatment sessions required was 4.41, ranging from 1-11. The ulcers gradually reduced in size with each session, ultimately leading to complete wound closure in 100% of cases.

Laser treatment made it possible to clear wounds of necrotic tissue and microbial bioburden without damaging viable tissue. The procedures were painless on an outpatient basis.

The RecoSMA laser operates by activating the body's innate healing processes, fostering neovascularization, and expediting tissue regeneration. This mechanism facilitates wound healing through re-epithelialization originating from the wound's edges and granulation emerging from the wound bed's depths, all without the formation of fibrosis. This unique approach promotes scar-free and unimpeded wound healing, a pivotal factor in effective rehabilitation.

Source: https://www.miragenews.com/research-confirms-new-recosma-laser-successful-1112434/